218 related articles for article (PubMed ID: 7943023)
1. Evaluation of school children at high risk for fragile X syndrome utilizing buccal cell FMR-1 testing.
Hagerman RJ; Wilson P; Staley LW; Lang KA; Fan T; Uhlhorn C; Jewell-Smart S; Hull C; Drisko J; Flom K
Am J Med Genet; 1994 Jul; 51(4):474-81. PubMed ID: 7943023
[TBL] [Abstract][Full Text] [Related]
2. DNA diagnosis of the fragile X syndrome in a series of 236 mentally retarded subjects and evidence for a reversal of mutation in the FMR-1 gene.
van den Ouweland AM; de Vries BB; Bakker PL; Deelen WH; de Graaff E; van Hemel JO; Oostra BA; Niermeijer MF; Halley DJ
Am J Med Genet; 1994 Jul; 51(4):482-5. PubMed ID: 7943024
[TBL] [Abstract][Full Text] [Related]
3. Screening for fragile X syndrome among Brazilian mentally retarded male patients using PCR from buccal cell DNA.
Christofolini DM; Lipay MV; Ramos MA; Brunoni D; Melaragno MI
Genet Mol Res; 2006 Jul; 5(3):448-53. PubMed ID: 17117359
[TBL] [Abstract][Full Text] [Related]
4. Direct mutation analysis of 495 patients for fragile X carrier status/proband diagnosis.
Kaplan G; Kung M; McClure M; Cronister A
Am J Med Genet; 1994 Jul; 51(4):501-2. PubMed ID: 7943028
[TBL] [Abstract][Full Text] [Related]
5. Systematic screening for fragile X syndrome in a cohort of 574 mentally retarded children.
Gérard B; Le Heuzey MF; Brunie G; Lewine P; Saiag MC; Cacheux V; Da Silva F; Dugas M; Mouren-Simeoni MC; Elion J; Grandchamp B
Ann Genet; 1997; 40(3):139-44. PubMed ID: 9401101
[TBL] [Abstract][Full Text] [Related]
6. Fragile X mental retardation syndrome: DNA diagnosis and carrier detection in New Zealand families.
Neville L; Cochrane J; Fitzgerald P; Kennedy M
N Z Med J; 1995 Oct; 108(1009):404-6. PubMed ID: 7478333
[TBL] [Abstract][Full Text] [Related]
7. Fragile X induction systems in CVS cultures: effect on cytogenetic, PCR, and genomic Southern Blot DNA analyses of the FMR-1 gene.
Jenkins EC; Morys I; Henderson J; Genovese M; Carter M; Li SY; Houck GE; Ding X; Stark-Houck SL; Dobkin CS
Am J Med Genet; 1994 Jul; 51(4):436-42. PubMed ID: 7943013
[TBL] [Abstract][Full Text] [Related]
8. High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression.
Hagerman RJ; Hull CE; Safanda JF; Carpenter I; Staley LW; O'Connor RA; Seydel C; Mazzocco MM; Snow K; Thibodeau SN
Am J Med Genet; 1994 Jul; 51(4):298-308. PubMed ID: 7942991
[TBL] [Abstract][Full Text] [Related]
9. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
10. Fragile X syndrome: a clinico-genetic study of mentally retarded patients in Kuwait.
Bastaki LA; Hegazy F; Al-Heneidi MM; Turki N; Azab AS; Naguib KK
East Mediterr Health J; 2004; 10(1-2):116-24. PubMed ID: 16201716
[TBL] [Abstract][Full Text] [Related]
11. [A genetic and molecular study of 85 families affected with the fragile X syndrome].
Milà Recasens M; Sánchez Díaz A; Glover López G; Castellví Bel S; Carbonell Meseguer P; Kruyer H; Ballesta Martínez F; Estivill Pallejà X
An Esp Pediatr; 1996 Mar; 44(3):250-6. PubMed ID: 8830601
[TBL] [Abstract][Full Text] [Related]
12. The fragile X continuum: new advances and perspectives.
Cornish K; Turk J; Hagerman R
J Intellect Disabil Res; 2008 Jun; 52(Pt 6):469-82. PubMed ID: 18444988
[TBL] [Abstract][Full Text] [Related]
13. Screening for fragile X syndrome.
Murray J; Cuckle H; Taylor G; Hewison J
Health Technol Assess; 1997; 1(4):i-iv, 1-71. PubMed ID: 9414543
[TBL] [Abstract][Full Text] [Related]
14. Assessment of a clinical checklist in the diagnosis of fragile X syndrome in India.
Guruju MR; Lavanya K; Thelma BK; Sujatha M; OmSai VR; Nagarathna V; Amarjyothi P; Jyothi A; Anandaraj MP
J Clin Neurosci; 2009 Oct; 16(10):1305-10. PubMed ID: 19560928
[TBL] [Abstract][Full Text] [Related]
15. A point mutation in the FMR-1 gene associated with fragile X mental retardation.
De Boulle K; Verkerk AJ; Reyniers E; Vits L; Hendrickx J; Van Roy B; Van den Bos F; de Graaff E; Oostra BA; Willems PJ
Nat Genet; 1993 Jan; 3(1):31-5. PubMed ID: 8490650
[TBL] [Abstract][Full Text] [Related]
16. A clinical checklist for fragile X syndrome: screening of Thai boys with developmental delay of unknown cause.
Limprasert P; Ruangdaraganon N; Vasiknanonte P; Sura T; Jaruratanasirikul S; Sriwongpanich N; Sriplung H
J Med Assoc Thai; 2000 Oct; 83(10):1260-6. PubMed ID: 11143494
[TBL] [Abstract][Full Text] [Related]
17. 10 years' experience in fragile X testing among mentally retarded individuals in Greece: a molecular and epidemiological approach.
Sofocleous C; Kitsiou S; Fryssira H; Kolialexi A; Kalaitzidaki M; Roma E; Tsangaris GT; Chistofidou C; Metaxotou C; Kanavakis E; Mavrou A
In Vivo; 2008; 22(4):451-5. PubMed ID: 18712171
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive screening of fragile X syndrome A using urine and hair roots.
Suwa K; Momoi MY
Brain Dev; 2004 Sep; 26(6):380-3. PubMed ID: 15275700
[TBL] [Abstract][Full Text] [Related]
19. Perspectives and molecular diagnosis of the fragile X syndrome.
Brown WT
Clin Lab Med; 1995 Dec; 15(4):859-75. PubMed ID: 8838227
[TBL] [Abstract][Full Text] [Related]
20. Molecular diagnosis and genetic counseling for fragile X mental retardation.
Pandey UB; Phadke SR; Mittal B
Neurol India; 2004 Mar; 52(1):36-42. PubMed ID: 15069237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
